[HTML][HTML] Deciphering the role of CD47 in cancer immunotherapy

L Weng, Y Wang, J Zhang, Q Wu, P Zhao, Y Shi… - Journal of Advanced …, 2024 - Elsevier
Background Immunotherapy has emerged as a novel strategy for cancer treatment following
surgery, radiotherapy, and chemotherapy. Immune checkpoint blockade and Chimeric …

Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma

J Dai, J Gao, H Dong - Aging (Albany NY), 2024 - pmc.ncbi.nlm.nih.gov
Low-grade glioma (LGG) is a grade II-III glioma accompanied by distinct clinical and
molecular characteristics and the studies related to its prognosis are still unclear. The …

From mechanism to therapy: the journey of CD24 in cancer

K Zhao, C Wu, X Li, M Niu, D Wu, X Cui… - Frontiers in …, 2024 - frontiersin.org
CD24 is a glycosylphosphatidylinositol-anchored protein that is expressed in a wide range
of tissues and cell types. It is involved in a variety of physiological and pathological …

Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition

Y Liu, S Zhao, Y Chen, W Ma, S Lu, L He, J Chen… - Cellular Oncology, 2023 - Springer
Purpose Glioma has been demonstrated as one of the most malignant intracranial tumors
and currently there is no effective treatment. Based on our previous RNA-sequencing data …

Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation

R Du, S Tripathi, H Najem, DJ Brat, RV Lukas, P Zhang… - Cells, 2024 - mdpi.com
Macrophages and microglia are professional phagocytes that sense and migrate toward “eat-
me” signals. The role of phagocytic cells is to maintain homeostasis by engulfing senescent …

[HTML][HTML] Targeting macrophages in cancer immunotherapy: Frontiers and challenges

Y Liu, H Tan, J Dai, J Lin, K Zhao, H Hu… - Journal of Advanced …, 2025 - Elsevier
Background Cancer immunotherapy has emerged as a groundbreaking approach in cancer
treatment, primarily realized through the manipulation of immune cells, notably T cell …

Isoglutaminyl Cyclase Overexpression Enhances KYSE30 Cancer Cell Proliferation and Migration via the MAPK Signaling Pathway

X Chen, X Yu, Y Cui, L Du, Q Zhou… - Journal of Proteome …, 2024 - ACS Publications
To understand how upregulated isoglutaminyl cyclase (isoQC) is involved in the initiation of
diseases such as cancer, we developed a human KYSE30 carcinoma cell model in which …

Role of CD61+ low-density neutrophils in promoting hepatocellular carcinoma metastasis through CCDC25 upregulation

X Guan, Y Lu, C Wang, P Zhan, Z Chen - International …, 2024 - Elsevier
Background A subset of neutrophils isolated from the peripheral blood mononuclear cells
(PBMC) layer has recently been described in cancer patients. Methods Double-gradient …

Prognostic implication of UBE2C+ CD8+ T cell in neoadjuvant immune checkpoint blockade plus chemotherapy for locally advanced esophageal cancer

Q Chen, S Mo, L Zhu, M Tang, J Cheng, P Ye… - International …, 2024 - Elsevier
Abstract Background Immune checkpoint blockers (ICBs) plus chemotherapy as
neoadjuvant therapy for patients with esophageal cancer (EC) has gained substantial …

Role of glutaminyl-peptide cyclo-transferase-like protein (QPCTL) in cancer: From molecular mechanisms to immunotherapy

EF Oghenemaro, S Uthirapathy, D Nathiya, P Kaur… - Gene, 2024 - Elsevier
Glutaminyl-peptide cyclotransferase-like protein (QPCTL) is a newly discovered enzyme that
has sparked interest owing to its possible role in cancer genesis and progression. Initially …